Silk Road Medical, Inc (SILK)
NASDAQ
Market Cap
$1.06B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
220 of 809
Rank in Industry
30 of 107
Largest Insider Buys in Sector
SILK Stock Price History Chart
SILK Stock Performance
About Silk Road Medical, Inc
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Insider Activity of Silk Road Medical, Inc
Over the last 12 months, insiders at Silk Road Medical, Inc have bought $198,783 and sold $738,499 worth of Silk Road Medical, Inc stock.
On average, over the past 5 years, insiders at Silk Road Medical, Inc have bought $202,642 and sold $187.27M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ballinger Kevin J. (director) — $397,566.
The last purchase of 11,700 shares for transaction amount of $198,783 was made by Ballinger Kevin J. (director) on 2024‑03‑05.
List of Insider Buy and Sell Transactions, Silk Road Medical, Inc
| 2024-03-05 | Sale | Buchanan Lucas W. | COO/CFO | 9,877 0.0255% | $17.17 | $169,578 | +13.14% | |
| 2024-03-05 | Sale | Davis Andrew S. | Chief Commercial Officer | 5,481 0.0141% | $17.17 | $94,103 | +13.14% | |
| 2024-03-05 | Sale | Ruedy Richard | EVPClin&Reg.Affairs&QA | 3,800 0.0098% | $17.17 | $65,242 | +13.14% | |
| 2024-03-05 | Sale | Klemz Kevin M | EVP/Chief Legal Officer/Sec. | 2,497 0.0064% | $17.17 | $42,871 | +13.14% | |
| 2024-03-05 | Sale | Jones Marie L. | VP, Finance and CAO | 2,602 0.0067% | $17.17 | $44,674 | +13.14% | |
| 2024-03-05 | Ballinger Kevin J. | director | 11,700 0.0298% | $16.99 | $198,783 | +13.14% | ||
| 2024-02-29 | Sale | Ruedy Richard | EVPClin&Reg.Affairs&QA | 3,000 0.0096% | $22.25 | $66,750 | +5.61% | |
| 2023-10-27 | Sale | Jones Marie L. | CAO and VP, Finance | 656 0.0017% | $6.61 | $4,334 | +149.78% | |
| 2023-10-04 | Sale | Buchanan Lucas W. | COO/CFO | 2,662 0.0069% | $15.22 | $40,524 | +6.89% | |
| 2023-08-17 | Sale | Klemz Kevin M | EVP/Chief Legal Officer/Sec. | 1,539 0.0038% | $20.11 | $30,942 | -20.95% | |
| 2023-08-03 | Sale | Davis Andrew S. | Chief Commercial Officer | 6,587 0.0178% | $22.13 | $145,797 | -20.44% | |
| 2023-07-11 | Sale | Rogers Erica J. | President and CEO | 1,000 0.0025% | $31.56 | $31,560 | -47.30% | |
| 2023-07-06 | Sale | Davis Andrew S. | Chief Commercial Officer | 69 0.0002% | $30.79 | $2,124 | -43.52% | |
| 2023-06-12 | Sale | Rogers Erica J. | President and CEO | 1,000 0.0026% | $32.13 | $32,130 | -45.84% | |
| 2023-05-11 | Sale | Rogers Erica J. | President and CEO | 3,000 0.0077% | $35.51 | $106,530 | -52.79% | |
| 2023-05-01 | Sale | Davis Andrew S. | Chief Commercial Officer | 6,753 0.0181% | $44.51 | $300,593 | -60.56% | |
| 2023-04-17 | Sale | WEATHERMAN ELIZABETH H | director | 5,000 0.0129% | $41.91 | $209,550 | -59.56% | |
| 2023-04-11 | Sale | Rogers Erica J. | President and CEO | 6,000 0.016% | $39.77 | $238,635 | -55.85% | |
| 2023-04-03 | Sale | Davis Andrew S. | Chief Commercial Officer | 6,753 0.0176% | $39.42 | $266,203 | -56.36% | |
| 2023-03-15 | Sale | WEATHERMAN ELIZABETH H | director | 5,000 0.0132% | $41.91 | $209,550 | -57.86% |
Insider Historical Profitability
0.04%
| Buchanan Lucas W. | COO/CFO | 500925 1.1191% | $26.81 | 0 | 33 | |
| Rogers Erica J. | President and CEO | 269639 0.6923% | $26.81 | 1 | 43 | +0.04% |
| Ruedy Richard | EVPClin&Reg.Affairs&QA | 205711 0.3736% | $26.81 | 0 | 9 | |
| Davis Andrew S. | Chief Commercial Officer | 287773 0.2812% | $26.81 | 0 | 38 | |
| Jones Marie L. | CAO and VP, Finance | 76894 0.1411% | $26.81 | 0 | 2 | |
| Klemz Kevin M | EVP/Chief Legal Officer/Sec. | 165194 0.0996% | $26.81 | 0 | 2 | |
| Ballinger Kevin J. | director | 17807 0.0455% | $26.81 | 1 | 0 | |
| WP X Finance, L.P. | 10 percent owner | 1021223 2.6222% | $26.81 | 0 | 5 | |
| WARBURG PINCUS & CO. | 10 percent owner | 1021223 2.6222% | $26.81 | 0 | 5 | |
| WEATHERMAN ELIZABETH H | director | 144454 0.3709% | $26.81 | 0 | 9 | |
| Chou Tony M. | director | 75707 0.1944% | $26.81 | 0 | 4 | |
| LASERSOHN JACK W | director | 4769 0.0122% | $26.81 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Wasatch Advisors | $83.35M | 11.54 | 4.55M | +12.36% | +$9.17M | 0.44 | |
| Capital World Investors | $57.01M | 7.89 | 3.11M | +4.89% | +$2.66M | 0.01 | |
| BlackRock | $54.46M | 7.54 | 2.97M | -1.31% | -$721,130.16 | <0.01 | |
| The Vanguard Group | $53.54M | 7.41 | 2.92M | +1.06% | +$562,900.32 | <0.01 | |
| Morgan Stanley | $33.58M | 4.65 | 1.83M | +6.16% | +$1.95M | <0.01 | |
| D. E. Shaw & Co. | $29.3M | 4.06 | 1.6M | +6.37% | +$1.75M | 0.04 | |
| Bellevue Group | $27.81M | 3.85 | 1.52M | +5.75% | +$1.51M | 0.42 | |
| Bamco | $27.48M | 3.8 | 1.5M | +28% | +$6.01M | 0.07 | |
| Sofinnova | $21.78M | 3.01 | 1.19M | New | +$21.78M | 0.05 | |
| Tri Locum Partners Lp | $19.85M | 2.75 | 1.08M | New | +$19.85M | 7 | |
| State Street | $19.02M | 2.63 | 1.04M | -20.82% | -$5M | <0.01 | |
| Kennedy Capital Management Inc | $18.98M | 2.63 | 1.04M | New | +$18.98M | 0.4 | |
| Armistice Capital Llc | $17.51M | 2.42 | 956,000 | -45.93% | -$14.88M | 0.21 | |
| Adage Capital Partners Gp L L C | $16.49M | 2.28 | 900,000 | -10% | -$1.83M | 0.03 | |
| Geode Capital Management | $16.08M | 2.23 | 877,850 | +2.04% | +$322,256.66 | <0.01 | |
| Arrowmark Colorado Holdings Llc | $15.83M | 2.19 | 864,151 | +4.98% | +$751,504.70 | 0.04 | |
| Rings Capital Management Llc | $15.76M | 2.18 | 860,004 | 0% | +$0 | 8.62 | |
| Goldman Sachs | $15.74M | 2.18 | 859,181 | -57.28% | -$21.1M | <0.01 | |
| Parkman Healthcare Partners Llc | $15.55M | 2.15 | 848,897 | +55.69% | +$5.56M | 1.92 | |
| Two Sigma | $14.62M | 2.02 | 797,984 | +35.75% | +$3.85M | 0.03 | |
| Two Sigma Advisers LP | $13.85M | 1.92 | 756,000 | +15% | +$1.81M | 0.02 | |
| TimesSquare Capital Management LLC | $12.31M | 1.7 | 672,134 | New | +$12.31M | 0.18 | |
| Schonfeld Group | $11.03M | 1.53 | 602,033 | +86.63% | +$5.12M | 0.08 | |
| Renaissance Technologies | $7.78M | 1.08 | 424,600 | +155.32% | +$4.73M | 0.01 | |
| Jacobs Levy Equity Management | $7.54M | 1.04 | 411,372 | +395.82% | +$6.02M | 0.03 | |
| Nuveen | $7.26M | 1.01 | 396,236 | +239.02% | +$5.12M | <0.01 | |
| Marshall Wace | $6.91M | 0.96 | 377,115 | +3.21% | +$214,582.20 | 0.01 | |
| Jefferies Financial Group | $6.59M | 0.91 | 359,800 | -81.13% | -$28.33M | 0.12 | |
| Healthcare Of Ontario Pension Plan Trust Fund | $6.47M | 0.9 | 353,000 | +59.01% | +$2.4M | 0.02 | |
| Deutsche Bank | $6.41M | 0.89 | 350,121 | +<0.01% | +$73.28 | <0.01 | |
| Northern Trust | $6.08M | 0.84 | 332,077 | -0.77% | -$47,174.00 | <0.01 | |
| PFM Health Sciences | $6.07M | 0.84 | 331,064 | New | +$6.07M | 0.17 | |
| Charles Schwab | $5.65M | 0.78 | 308,467 | +9.69% | +$499,219.96 | <0.01 | |
| Invesco | $4.89M | 0.68 | 266,804 | +1,260.69% | +$4.53M | <0.01 | |
| American Century Investments | $4.57M | 0.63 | 249,200 | +10.4% | +$430,208.56 | <0.01 | |
| Millennium Management LLC | $4.28M | 0.59 | 233,698 | +61.89% | +$1.64M | <0.01 | |
| Canada Pension Plan Investment Board | $4.09M | 0.57 | 223,000 | New | +$4.09M | <0.01 | |
| Bank of America | $3.9M | 0.54 | 212,737 | -16.93% | -$794,263.63 | <0.0001 | |
| Cibc World Markets Corp | $3.66M | 0.51 | 200,000 | New | +$3.66M | 0.02 | |
| HSBC | $3.29M | 0.46 | 179,377 | New | +$3.29M | <0.01 | |
| Acadian Asset Management | $3.1M | 0.43 | 169,346 | -48.23% | -$2.89M | 0.01 | |
| Birchview Capital Lp | $2.9M | 0.4 | 158,094 | 0% | +$0 | 0.16 | |
| Tudor Investment Corp Et Al | $2.59M | 0.36 | 141,175 | +18.46% | +$403,058.32 | 0.03 | |
| SEI Investments Company | $2.55M | 0.35 | 139,282 | +26.14% | +$528,732.64 | <0.01 | |
| Point72 Asset Management | $2.5M | 0.35 | 136,432 | +68,116% | +$2.5M | 0.01 | |
| Bullseye Asset Management LLC | $2.41M | 0.33 | 131,718 | 0% | +$0 | 1.13 | |
| Citadel Advisors LLC | $2.26M | 0.31 | 123,540 | -49.7% | -$2.24M | <0.01 | |
| BNY Mellon | $2.12M | 0.29 | 115,663 | -9.28% | -$216,798.86 | <0.0001 | |
| PDT Partners | $2.03M | 0.28 | 111,037 | -23.59% | -$627,826.45 | 0.15 | |
| Qube Research & Technologies | $1.95M | 0.27 | 106,548 | +3.29% | +$62,159.78 | <0.01 |